Product Images Medroxyprogesterone Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Medroxyprogesterone Acetate NDC 68071-4666 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

68071 4666 5

68071 4666 5

The text appears to be a label of a pharmaceutical product manufactured by NuCare Pharmaceuticals Inc. The product is MedroxyPROGESTERone Acetate 150mg, which contains certain ingredients. The label also specifies its lot number, NDC, warning to keep it out of reach of children, and other important details such as manufacturing and expiration date. It also includes a warning to call a doctor in case of any side effects and advises to store the product at a controlled temperature.*

Chemical Structure - medroxyprogesterone 01

Chemical Structure - medroxyprogesterone 01

Figure 1 - medroxyprogesterone 02

Figure 1 - medroxyprogesterone 02

Figure 2 - medroxyprogesterone 03

Figure 2 - medroxyprogesterone 03

Chart - medroxyprogesterone 04

Chart - medroxyprogesterone 04

This text provides information about various birth control methods and their effectiveness in terms of pregnancy prevention. It indicates that some methods, such as implants, injections, intrauterine devices, and sterilization, are highly effective, while others, like birth control pills, condoms, diaphragms, and spermicide, have a lower rate of preventing pregnancy. It also mentions natural methods like tracking fertile days and withdrawal, but notes that they may not be as reliable as other forms of birth control. The text does not provide a clear description or context and does not present a complete picture of birth control methods.*

figure 1 - medroxyprogesterone 05

figure 1 - medroxyprogesterone 05

Figure 1 displays the risk estimates for breast cancer in DMPA (depot medroxyprogesterone acetate) users in the form of odds ratios with 95% confidence intervals presented on a logarithmic scale. Non-readable characters make interpretation difficult.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.